Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q2 Loss of 21c/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $54.87 -0.76%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q2 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
